At the health systems level, lack of diagnostic ability, inadequate access to trained providers, and limited drug availability provide significant barriers to cancer care delivery. This article outlines an urgent call to action to improve access to precision oncology therapies in lower‐ and middle‐income countries, drawing upon lessons from international efforts in oncology and infectious disease.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100554 | PMC |
http://dx.doi.org/10.1002/onco.13708 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!